Spectral AI, Inc. Price & Performance (MDAI)

Spectral AI has raised up to $15 million in funding, including an $8.5 million initial debt draw and $2.7 million in equity financing. This funding aims to accelerate the U.S. commercialization of its AI-driven DeepView System, which predicts burn healing potential. FDA clearance is required for further financing tranches.12

Spectral AI's Burn Validation Study revealed its DeepView System achieved an 86.6% accuracy in identifying non-healing burn tissue, compared to 40.8% by traditional physician evaluations. The AI system’s performance highlights its potential to transform burn care by improving clinical decisions and patient outcomes.34

Spectral AI has filed for an IPO of its subsidiary, Spectral IP, under the proposed ticker 'SMIP.' This strategic move aims to unlock value by separating its intellectual property assets. The IPO could generate capital while maintaining focus on its flagship DeepView System for burn assessment.5